Bioassays and Metabolic Assays for Evaluating GLP-1, GIP, and Glucagon Therapeutics
Time: 12:30 pm
day: Day Two
Details:
- Measuring Drug Activity – Functional bioassays quantify potency and efficacy of GLP-1, GIP, and glucagon receptor agonists
- Metabolic Insights – Lipid and glucose assays assess drug effects on fat storage, breakdown, and insulin sensitivity
- Optimizing Therapeutic Development – Integrated assay strategies provide a comprehensive view of incretin-targeting drug mechanisms
